| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |